CANCER OF UNKNOWN PRIMARY SITE

Clinical trials for CANCER OF UNKNOWN PRIMARY SITE explained in plain language.

Never miss a new study

Get alerted when new CANCER OF UNKNOWN PRIMARY SITE trials appear

Sign up with your email to follow new studies for CANCER OF UNKNOWN PRIMARY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 1 Completed 3

Scientists test new 'Tumor Glow' scan for Hard-to-Spot cancers

Knowledge-focused Ongoing

This early-stage study is testing a new imaging agent called 68Ga-FAPI-46 to see where it goes in the body of patients with many different types of cancer. The goal is to understand if this tracer can help doctors better see and understand tumors by highlighting specific cells ar…

Matched conditions: CANCER OF UNKNOWN PRIMARY SITE

Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:32 UTC

CANCER OF UNKNOWN PRIMARY SITE

Get alerted when new CANCER OF UNKNOWN PRIMARY SITE trials appear

Scientists test new 'Tumor Glow' scan for Hard-to-Spot cancers